BRILINTA 90 MG AstraZeneca

270.00

SKU: EU21361 Categories: ,
Description

Buy BRILINTA 90 MG AstraZeneca in America? – why our customers choose us

When it comes to purchasing BRILINTA 90 MG AstraZeneca, our platform is designed to cater to the unique needs of athletes and fitness enthusiasts. We prioritize quality, offering only authentic medications directly sourced from trusted suppliers. Our customers choose us for our commitment to transparency, competitive pricing, and exceptional customer service. Understanding the significance of proper pharmacological support in sports can enhance performance and recovery, which is why many athletes have turned to us for their health needs. Our easy ordering process and knowledgeable support team ensure you have a seamless experience, making us the go-to option for those serious about performance enhancement.

Basic description, what it is and who it’s for

BRILINTA 90 MG, manufactured by AstraZeneca, is primarily an antiplatelet medication aimed at preventing blood clots. It plays a crucial role in managing acute coronary syndrome (ACS) and is often prescribed to patients who have experienced heart attacks or unstable angina. However, in the sports community, it’s gaining attention for its potential to assist athletes in enhancing blood flow and reducing recovery times after intense activities.

Athletes looking to improve their cardiovascular efficiency may find BRILINTA beneficial. By improving circulation and oxygen delivery to muscles, it can be particularly advantageous for endurance athletes. This application, while not officially approved for performance enhancement, highlights the need for individuals to understand both the potential benefits and risks associated with off-label use.

Mechanism of action, processes at the cellular level

The primary mechanism of action of BRILINTA revolves around its active ingredient, ticagrelor. This medication works by inhibiting the ADP (adenosine diphosphate) pathway in platelets, which plays a pivotal role in the aggregation process that leads to clot formation.

At the cellular level, BRILINTA binds to the P2Y12 receptor on the surface of platelets. When this receptor is activated, it triggers a cascade of events leading to platelet activation and aggregation, which can result in blood clot formation. By blocking this receptor, BRILINTA effectively reduces the platelets’ ability to clump together, thereby improving blood flow and reducing the risk of blockages in cardiovascular pathways.

This cellular action not only helps in medical scenarios but can also theoretically enhance athletic performance by ensuring that muscle tissues receive adequate oxygen and nutrients, thus optimizing strength and endurance during training and competition.

Benefits, increased strength and performance

While BRILINTA is not a performance-enhancing drug in the traditional sense, its potential benefits for athletes cannot be overlooked. Some of the positive impacts noted by users include:

  • Improved blood circulation leading to enhanced oxygen delivery to muscles.
  • Reduced fatigue during prolonged physical activities.
  • Faster recovery times from intense workouts or competitions.
  • Potential to lower the risk of heart-related issues in high-stress sporting environments.
  • Support for overall cardiovascular health.

These effects can lead to an increase in overall strength and performance, especially in endurance-based sports. However, it is important to remember that individual responses to medication can vary, and what works for one athlete may not work for another.

Safety guidelines BRILINTA 90 MG AstraZeneca

Before considering BRILINTA as part of your training regimen, it’s essential to adhere to safety guidelines:

  1. Consult a healthcare professional before starting any new medication, especially for off-label use.
  2. Be aware of potential side effects, including bleeding complications.
  3. Do not mix BRILINTA with other blood-thinning medications unless advised by a doctor.
  4. Monitor your body’s response to the medication closely, particularly during intensive training.
  5. Ensure regular check-ups to evaluate your cardiovascular health and adjust the medication as necessary.

In conclusion, while BRILINTA 90 MG AstraZeneca is known for its role in preventing heart-related issues, its potential applications in the sports world are slowly gaining attention. Athletes seeking to optimize performance should carefully weigh the benefits against the risks, considering the importance of professional medical guidance throughout any pharmacological intervention.

Additional information
Active substance

Ticagrelor

Water Retention

None

Hepatotoxicity

Low risk

Lab Test

Not specific, may monitor platelet function tests

Also known as

AZD6140

Blood pressure

Can cause transient increase

Trade name

Brilinta, Brilique, Possia

FORM

56 pills x 90 mg

Storage conditions

Store at room temperature away from moisture and heat

Chemical name

(1S,2S,3R,5R)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

Formula

C23H28F2N6O4S

Substance class

Antiplatelet agent

Main action

Platelet aggregation inhibitor

Half-life

Approximately 7 to 8.5 hours

Dosage (medical)

Typically 90 mg twice daily

Dosage (sports)

Not applicable

Effects

Reduces the rate of stent thrombosis in patients who are at risk, decreases myocardial infarction

Side effects

Bleeding, dyspnea, headache, cough, hypertension, nausea

Use in sports

Not typically used in sports

Manufacturer

AstraZeneca

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “BRILINTA 90 MG AstraZeneca”

Your email address will not be published. Required fields are marked *

Shipping & Delivery